Martin Shkreli (MediaPunch via AP Images)
Martin Shkreli-associated companies settle anti-competitive lawsuit with insurer for $28M
One of Martin Shkreli’s last legacies in the pharma industry may be a $28 million settlement with an insurance network.
Almost a year after Blue …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
